The mechanisms by which mucosal homeostasis is maintained are of central importance to inflammatory bowel disease. Critical to these processes is the intestinal epithelial cell (IEC), which regulates immune responses at the interface between the commensal microbiota and the host 1, 2 . CD1d presents self and microbial lipid antigens to natural killer T (NKT) cells, which are involved in the pathogenesis of colitis in animal models and human inflammatory bowel disease [3] [4] [5] [6] [7] [8] . As CD1d crosslinking on model IECs results in the production of the important regulatory cytokine interleukin (IL)-10 (ref. 9) , decreased epithelial CD1d expression-as observed in inflammatory bowel disease 10, 11 -may contribute substantially to intestinal inflammation. Here we show in mice that whereas bone-marrowderived CD1d signals contribute to NKT-cell-mediated intestinal inflammation, engagement of epithelial CD1d elicits protective effects through the activation of STAT3 and STAT3-dependent transcription of IL-10, heat shock protein 110 (HSP110; also known as HSP105), and CD1d itself. All of these epithelial elements are critically involved in controlling CD1d-mediated intestinal inflammation. This is demonstrated by severe NKT-cell-mediated colitis upon IEC-specific deletion of IL-10, CD1d, and its critical regulator microsomal triglyceride transfer protein (MTP) 12, 13 , as well as deletion of HSP110 in the radioresistant compartment. Our studies thus uncover a novel pathway of IEC-dependent regulation of mucosal homeostasis and highlight a critical role of IL-10 in the intestinal epithelium, with broad implications for diseases such as inflammatory bowel disease.
To examine the function of CD1d in the intestinal epithelium, we generated mice with tamoxifen-inducible IEC-specific deletion of MTP, a lipid transfer protein encoded by Mttp and required for CD1d function 12 Fig. 2a ) and endoplasmic reticulum (ER) stress (Extended Data Fig. 2b ), but showed decreased IEC-mediated, CD1d-but not major histocompatibility complex (MHC)-class-I-dependent antigen presentation despite unimpaired CD1d expression (Extended Data Fig. 3a , b, c left). Mttp DIEC mice exhibited increased sensitivity to oxazolone-induced colitis, a CD1d-and NKT-cell-dependent colitis model 4 , as shown by increased mortality (Fig. 1a, left) , weight loss (Fig. 1a , right) and histological injury ( mice). Increased severity of colitis was not caused by primary epithelial barrier defects (Extended Data Fig. 4a ) but was due to loss of function of intestinal epithelial CD1d. Thus, bone marrow chimaeras with selective deficiency of CD1d in the radioresistant compartment exhibited severe mortality and morbidity in the oxazolone model (Fig. 1c, d ), increased production of pathogenic IL-13 and IL-1b in colon explants ( Fig. 1e ) and purified CD11b
1 lamina propria cells (Extended Data Fig. 4b ), and reduced secretion of protective IL-10 ( Fig. 1e ). In accordance with a protective role of intestinal epithelial CD1d, its expression was upregulated in response to oxazolone colitis in wild-type, but not Mttp DIEC , mice (Extended Data Fig. 3c , right). Intriguingly, pathogenic signals were similarly CD1d-dependent but emanated from non-epithelial cells in a manner dependent on adaptive immune cells. Thus, Mttp DIEC mice on a Rag1 2/2 or Cd1d1 2/2 Cd1d2 2/2 (CD1d-knockout) background were protected from oxazolone colitis (Extended Data Fig. 4c, d ). Consistent with a role of non-epithelial cells in the delivery of pathogenic CD1d signals, antibody-mediated neutralization of (non-epithelial) CD1d in Mttp DIEC mice reduced the severity of oxazolone-induced colitis (Fig. 1f, g ). Thus, intestinal epithelial CD1d-and MTP-dependent lipid antigen presentation protects from oxazolone colitis, whereas CD1d-and NKT-cellmediated inflammation emanates from non-epithelial cells, presumably bone-marrow-derived lamina propria cells.
To investigate directly the role of epithelial CD1d, we developed mice with inducible, IEC-specific deletion of CD1d (Villin-CreER T2 3 Cd1d1 fl/fl ; hereafter referred to as Cd1d1 DIEC ) (Extended Data Fig. 5a ). Tamoxifentreated Cd1d1 DIEC mice exhibited normal numbers of invariant (i)NKT cells and lacked intestinal epithelial expression of CD1d and CD1d-but not MHC-class-I-mediated antigen presentation by IECs (Extended Data Fig. 5b-e) . Oxazolone-challenged Cd1d1 DIEC mice, like Mttp DIEC mice, exhibited increased mortality (Fig. 1h , left), weight loss (Fig. 1h , right), histopathological injury (Fig. 1i) , colon shortening (Extended Data Fig. 5f ) and elevated secretion of IL-13 and IL-1b, as well as impaired secretion of IL-10 from colon explant cultures (Fig. 1j) . Moreover, colonic iNKT cells from Cd1d1 DIEC mice showed increased IL-13 and IFN-c expression in oxazolone colitis (Fig. 1k) . Thus, intestinal epithelial CD1d protects from intestinal inflammation.
To gain insight into the mechanisms underlying protection by intestinal epithelial CD1d, we performed transcriptional profiling of intestinal mucosal scrapings from wild-type and Mttp DIEC mice in the oxazolone model (Extended Data Table 1 and data not shown). HSP110, encoded by Hsph1, exhibited decreased expression in Mttp DIEC mice (Fig. 2a) , which was of interest given its known role in induction of epithelial CD1d expression 16 . In line with a potential MTP-and CD1d-dependent role of *These authors contributed equally to this work.
HSP110 in intestinal inflammation, HSP110 messenger RNA (Fig. 2b , left) and protein expression (Extended Data Fig. 6a ) were increased in IECs from wild-type but not Mttp DIEC mice upon oxazolone challenge. Similar observations were made for Cd1d1 DIEC mice (Fig. 2b, right) . In addition, intestinal epithelial but not lamina propria HSP110 expression was reduced in active and inactive human ulcerative colitis compared with healthy controls (Fig. 2c and Extended Data Fig. 6b ), which is in accordance with impaired epithelial CD1d expression in inflammatory bowel disease, as previously reported 10 . Furthermore, consistent with regulation of CD1d expression by HSP110 (ref. 16) , oxazolone colitis was associated with induction of CD1d expression in wild-type but not Mttp DIEC IECs (Extended Data Fig. 3c, right) . Together, these data indicate that IEC CD1d and MTP are required for epithelial HSP110 upregulation during oxazolone-induced colitis and that alterations in this pathway are observed in human ulcerative colitis.
To understand better the functional consequences of epithelial HSP110 deficiency observed in Mttp DIEC and Cd1d1 DIEC mice, bone marrow chimaeras of HSP110-knockout (HSP110-KO) or wild-type mice receiving wild-type bone marrow were studied. Compared with wild-type recipients, HSP110-knockout recipients of wild-type bone marrow exhibited increased mortality and weight loss (Fig. 2d) , microscopic injury ( Fig. 2e) and increased IL-13 and IL-1b secretion (Fig. 2f ) in the oxazolone model. Morbidity and mortality in HSP110-knockout recipients of wild-type bone marrow reflected that observed for conventional HSP110-knockout mice, suggesting critical, protective effects of HSP110 in the radioresistant compartment, including IECs (Extended Data Fig. 6c ). Antibody-mediated neutralization of CD1d reduced the severity of colitis in HSP110-knockout bone marrow chimaeras, in line with pathogenic CD1d-dependent signals originating from nonepithelial lamina propria cells (Fig. 2d, f) . Together, these studies indicate Ox. EtOH Cd1d1 ΔIEC (EtOH) n = 5
Cd1d1 ΔIEC (ox.) n = 5 P = 0.037 
Mttp ΔIEC (19G11) n = 10
Cd1d1 ΔIEC (ox.) n = 13 , cytokine secretion (enzyme-linked immunosorbent assay (ELISA)) in colon explant cultures (e, j), and cytokine expression (quantitative polymerase chain reaction (qPCR)) of sorted colonic iNKT cells combined from intraepithelial and lamina propria compartments (k) of the indicated mice upon rectal challenge with oxazolone (ox., a-k) or vehicle (ethanol (EtOH, a-e, h-j)). c-e, Wild-type (WT) and CD1d-knockout (CD1d-KO) mice were reconstituted with wild-type bone marrow. f, g, 19G11 (antiCD1d) or isotype control antibody (IgG2b) were administered. Results representative of three independent experiments are shown. Mean 6 standard error of the mean (s.e.m.) of the indicated number of mice is shown. j, Right, Mann-Whitney U-test was applied. In all other panels, Student's t-test or log-rank test (survival) were applied.
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that reduced HSP110 expression in the absence of functional epithelial CD1d may contribute to severe oxazolone colitis. Consistent with this hypothesis, reconstitution of HSP110 expression by adenoviruses targeting IECs (Fig. 2g ) ameliorated oxazolone-induced colitis in Mttp DIEC mice, as shown by decreased mortality (Fig. 2h, left) , weight loss (Fig. 2h , right) and microscopic injury (Fig. 2i) . It is noteworthy that adenoviruses also A 
Mttp ΔIEC (AdHSP110) n = 5 
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targeted lamina propria cells (Fig. 2g) , which may have contributed to protection from intestinal inflammation. As mice with an IEC-specific deficiency in MTP and CD1d exhibited impaired epithelial expression of HSP110, we tested whether engagement of epithelial CD1d supports HSP110 expression. To this end, we investigated HSP110 in purified (Extended Data Fig. 7 ) colonic IECs after antibody-mediated CD1d crosslinking, a treatment previously shown to induce production of barrier-protective IEC-derived IL-10 (ref. 9 ). CD1d crosslinking led to increased expression of Il10 (Fig. 2j) and Hsph1 (Fig. 2k) in IECs from wild-type but not Mttp DIEC mice. Similar observations were made upon in vitro co-culture of NKT cells with a mouse IEC line (Fig. 2l) . Previous studies in a cultured human IEC line suggested that epithelial IL-10 production upon CD1d crosslinking is elicited through retrograde signalling dependent on the cytoplasmic tail of CD1d 9 . We therefore investigated whether bone marrow chimaeras with selective deletion of the cytoplasmic CD1d tail (hereafter referred to as tail-deleted (TD)-CD1d) in radioresistant cells exhibit impaired expression of Il10 and Hsph1 in purified IECs. Indeed, IECs obtained from these mice showed impaired expression of Il10 and Hsph1 under constitutive conditions and reduced expression after administration of the CD1d-binding, 
Mttp ΔIEC (AdHSP110+IL-10R) P = 0.005 (Fig. 2m ). These data demonstrate that engagement of epithelial CD1d induces expression of HSP110 and IL-10, presumably through retrograde CD1d signalling. Additional effects of the CD1d cytoplasmic tail, such as regulation of intracellular CD1d trafficking 17 and potential effects on NKT cell homing 5 , may further contribute to protection from intestinal inflammation.
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As the Il10, Hsph1 and Cd1d1 genes contain STAT sites in their promoters (ref. 18 and T.O. et al., unpublished observations), and as Hsph1 and Cd1d1 exhibit reduced expression in Stat3-deficient IECs (Gene Expression Omnibus accession number GSE15955) 19 , we reasoned that STAT3 may contribute to Il10 and Hsph1 expression downstream of CD1d. Indeed, epithelial STAT3 became phosphorylated in response to CD1d engagement by antibody crosslinking (Fig. 3a, left) and iNKT-cell co-culture (Fig. 3a , right, and Extended Data Fig. 8a) . Moreover, impaired epithelial STAT3 phosphorylation was observed in Cd1d1 DIEC mice (Fig. 3b) and TD-CD1d recipients of wild-type bone marrow (Fig. 3c) . Furthermore, short interfering RNA (siRNA)-mediated knockdown of Stat3 in the IEC line MODE-K (Extended Data Fig. 8b ) led to reduced expression of Cd1d1, Hsph1 and Il10 (Fig. 3d) . Together, these data demonstrate that STAT3 acts downstream of epithelial CD1d to induce expression of Il10, Hsph1 and Cd1d1.
IL-10 and HSP110 do not only exhibit STAT3-dependent expression but also signal via STAT3 (refs 18, 20) and may thus further contribute to sustained activation of epithelial STAT3 and STAT3-dependent expression of Cd1d1, Il10 and Hsph1. Consistent with this concept, both recombinant and adenoviral HSP110 induced epithelial expression of Il10 and Cd1d1 in MODE-K cells, which was abrogated upon siRNAmediated knockdown of Stat3 (Fig. 3e, f) . Similar findings were made in vivo, as adenoviruses expressing HSP110, but not LacZ, restored epithelial expression of IL-10 in Cd1d1 DIEC mice in the oxazolone model (Fig. 3g, h ). These data demonstrate that HSP110 acts in a STAT3-dependent manner to support the expression of IL-10 and CD1d by IECs. Given HSP110-dependent regulation of epithelial IL-10 expression, we investigated whether the protective effects of HSP110 are dependent on IL-10. CD11b
1 lamina propria cells from Cd1d1 DIEC mice showed decreased phosphorylated (p)STAT3 expression in oxazolone colitis, consistent with decreased IL-10 production by IECs and IL-10 receptor (IL-10R) signalling by lamina propria cells (Fig. 3i) . Moreover, antibodymediated IL-10R blocking prevented adenoviral HSP110-dependent amelioration of colitis (Fig. 3j-l) . To investigate further the role of epithelial IL-10, we generated Il10 2/2 bone marrow chimaeras. Il10 deletion in the radioresistant compartment resulted in increased mortality (Fig. 4a) and colonic IL-13 production (Fig. 4b ) in the oxazolone model. Moreover, a similar trend was observed in mice with Il10 deletion in the radiosensitive compartment (Fig. 4a, b) . These data thus reveal that, in addition to the established role of bone-marrow-derived cells in IL-10-mediated control of intestinal inflammation 21, 22 , IL-10 derived from radioresistant cells provides an additional, non-redundant pathway required for regulation of intestinal inflammation. To address whether protective IL-10 originates from the intestinal epithelium, we investigated oxazolone colitis in mice with inducible, epithelial-specific deletion of Il10 (Villin-CreER T2 3 Il10
; hereafter referred to as Il10
DIEC
). Similar to mice with IEC-specific deletion of Mttp and Cd1d1 and mice with deletion of Hsph1 and Il10 in the radioresistant compartment, Il10 DIEC mice exhibited increased mortality (Fig. 4c ), weight loss ( Fig. 4d ) and histopathological inflammation (Fig. 4e ) in the oxazolone model. Furthermore, in accordance with STAT3-mediated signalling by IL-10 (ref. 18 ) and STAT3-dependent expression of Hsph1 and Cd1d1 (Fig. 3d) , IEC-specific Il10 deletion was associated with reduced epithelial expression of Hsph1 and a trend towards a reduction in Cd1d1 expression in the oxazolone model (Fig. 4f ). These results demonstrate that IEC-derived 
Il10 ΔIEC (Ox.) n = 11 
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IL-10, downstream of epithelial CD1d, HSP110 and STAT3 is critical for regulation of intestinal inflammation. NKT cells are central mediators of intestinal inflammation 3, 4 . In studies aiming to identify the cellular origin of pathogenic lipid antigen presentation in oxazolone colitis, we made the unanticipated observation that intestinal epithelial CD1d protects from intestinal inflammation in a manner dependent on STAT3, IL-10 and HSP110, whereas pathogenic NKT-cell activation emanates from bone-marrow-derived cells in a CD1d-restricted fashion (Extended Data Fig. 1a) . As further outlined in the Supplementary Discussion and Extended Data Fig. 9 , such opposing roles of CD1d-restricted presentation by bone-marrowderived and epithelial cells are at least partially dependent on the expression of co-stimulatory molecules such as CD40. Our findings highlight the role of the intestinal epithelium as a key regulator of mucosal immunity and underscore the important role of intestinal epithelial CD1d and IL-10 in determining the host's response to environmental stimuli, which activate CD1d-restricted NKT cells 5 .
METHODS SUMMARY
Mice were housed in a specific pathogen-free (SPF) barrier facility. 6 bone marrow cells were delivered intravenously. Oxazolone colitis was induced as described previously 4 and as outlined in Methods. Where indicated, mice received 1 mg of neutralizing antibodies against IL-10R (R&D), CD1d (19G11, BioXcell) or isotype control intraperitoneally (i.p.), or 5 3 10 8 adenoviruses in PBS i.p., each before skin sensitization and before and 2 days after rectal oxazolone challenge. For a schematic overview of procedures please refer to Extended Data Fig. 1b .
Online Content Any additional Methods, Extended Data display items and Source Data are available in the online version of the paper; references unique to these sections appear only in the online paper.
METHODS
Mice. Mice (C57BL/6J unless indicated otherwise) were housed in a specific pathogenfree (SPF) barrier facility. ) mice have been described. To generate the floxed/neo Cd1d1 allele, a LoxP (L83) site at 10310 and a FNFL (Frt-Neo-Frt-LoxP) cassette at 12190 was inserted to flank exon 2, 3 and 4 (about 1.9 kb) of the Cd1d1 gene. A gene-targeting vector was constructed by retrieving one 5 kb long homology arm (59 to L83), one 1.9 kb sequence containing exon 2/3/4, FNFL cassette, and one 2 kb short homology arm (end of FNFL to 39). The FNFL cassette conferred G418 resistance during gene targeting in PTL1 (129B6 hybrid) embryonic stem (ES) cells. The Cd1d1 allele was PCR amplified and sequenced to confirm the targeted C57BL/6J allele based on the C57BL/6J-specific mutation in Cd1d2 allele 28 . Three targeted ES cells with targeted C57BL/6J allele were injected into C57BL/6J blastocysts to generate chimaeras. Male chimaeras were bred to bACTFlpe females or EIIa-Cre females to transmit the floxed Cd1d1 allele (Cd1d1 To activate Cre recombinase, 4-5-week-old Villin-CreER T2 mice were orally gavaged daily with 1 mg tamoxifen for a total of 5 days. For bone marrow chimaeras, recipients received total body irradiation of 1,100 rad in two separate doses 4 h apart. The next day, 0.5 3 10 6 bone marrow cells were delivered intravenously. For a-GalCer studies, mice were injected with 2 mg of a-GalCer (KRN7000, Avanti Polar Lipids) intraperitoneally (i.p.) 8 weeks after bone marrow reconstitution and RNA was isolated from Percoll-purified IECs (see later) 12 h after injection. For oxazolone colitis, mice were pre-sensitized by abdominal skin application of 3% (w/v) oxazolone in 100% ethanol, followed by rectal administration of 1% oxazolone in 50% ethanol after 5 days. Where indicated, mice received 1 mg of neutralizing antibodies against IL-10R (R&D), CD1d (19G11, BioXcell) or isotype control i.p., or 5 3 10 8 adenoviruses in PBS i.p., each before skin sensitization and before and 2 days after rectal oxazolone challenge. Body weight, rectal bleeding and stool consistency were analysed on a daily basis. Tissues were examined for evidence of colitis by five established criteria for colitis activity in a blinded fashion by a pathologist (J.G.): hypervascularization, presence of mononuclear cells, epithelial hyperplasia, epithelial injury, and presence of granulocytes. For a schematic overview of procedures please refer to Extended Data Fig. 1b .
Animal studies were conducted in a gender-and age-matched manner using littermates for each experiment. Both male and female mice were used and were 8 weeks of age at the time of experiments (11-16 weeks of age for bone marrow chimaera studies). The number of animals used per group was based on previous experimental results and observed variability. Histopathology analysis was performed in a blinded manner. For all other in vitro and in vivo analyses, investigators were not blinded to treatment allocation. Animal studies were performed in compliance with ethical regulations and were approved by the ethics committees of Harvard Medical School and the Christian Albrechts University. Patients. Human studies were approved by the ethics committee of the Ludwig Maximilians University. All subjects provided written informed consent. Immunohistochemical staining was performed on intestinal biopsies from ten healthy controls (patients undergoing screening colonoscopy without detection of malignancy), four patients with active ulcerative colitis, and five patients with inactive ulcerative colitis. Isolation of IECs and lymphocytes, flow cytometry, and sorting. To isolate IECs, the intestines were opened, washed in cold PBS, cut into pieces, and transferred into tubes containing HBSS without calcium and magnesium. After the addition of dithiothreitol (DTT) at 1 mM (Sigma), intestines were shaken at 250 r.p.m. for 10 min at room temperature to remove mucus. After washing in PBS, tissues were incubated in RPMI-1640 with 1 U ml 21 Dispase (Roche) for 30-40 min at 37 uC at 250 r.p.m. After filtering through a 100 mm strainer and centrifugation for 5 min at 1,500 r.p.m., the pellet was resuspended in 5 ml of 100% Percoll and placed beneath 8 ml of 40% Percoll. After centrifugation for 20 min at 1,500 r.p.m. the top layer was removed, washed three times in PBS and used as IECs.
To isolate intraepithelial (IEL) and lamina propria lymphocytes, large intestines were collected, fat tissue removed, the intestines cut longitudinally and washed in PBS in order to remove faecal content, cut into 30 mm pieces, and shaken in RPMI-1640 containing 20 mM HEPES, 1 mM DTT and 5 mM EDTA for 30 min at 37 uC. To isolate IELs, cells derived from the epithelial compartment were resupended in 4 ml of 40% Percoll and layered on top of 2 ml of 75% Percoll. After centrifugation for 20 min at 2,000 r.p.m. the middle layer was removed, washed in 2% FBS in PBS and the IELs were obtained. For lamina propria lymphocytes, the non-epithelial compartment was washed in PBS, cut into smaller pieces and incubated in RPMI-1640 containing 5% FBS, 1.5 mg ml 21 collagenase type II and 0.5 mg ml 21 dispase (GIBCO) for 1 h at 37 uC under constant horizontal shaking (250 r.p.m.). The digested tissues were filtered through a 40 mm strainer and, after Percoll gradient centrifugation and washing as described earlier, were used as lamina propria lymphocytes in flow cytometry. Where indicated, CD11b
1 lamina propria cells were purified using magnetic beads according to the manufacturer's instructions (Miltenyi Biotec). Liver lymphocytes were prepared as described before 29 . Primary iNKT cells were sorted by double staining with PBS57-loaded CD1d tetramers and CD3e using a BD FACSAria II SORP UV sorter. RNA samples were prepared using an RNeasy Micro Kit and cDNAs were synthesized using the Omniscript RT Kit (Qiagen).
PBS57-loaded or -unloaded CD1d tetramers were obtained from the NIH Tetramer Core Facility. Flow cytometry antibodies were obtained from eBiosciences. Flow cytometry was performed using a MACSQuant (Miltenyi Biotec) and a BD FACSVerse (BD Biosciences) and data were analysed with FlowJo software (TreeStar). Antigen presentation assays. Freshly isolated IECs, MODE-K cells 30 , and CD11c-magnetic-bead-purified (Miltenyi Biotec) splenic dendritic cells were incubated with 100 ng ml 21 a-GalCer for 4 h, washed three times with PBS, and aliquoted into 96-well plates at 1 3 10 5 cells per well. NKT-cell hybridomas (24.7, DN32.D3 and 14S. 6 (ref. 31) ) were added at a 1:1 ratio. Where indicated, soluble, stimulatory CD28 antibody was added (1 mg ml 21 ; clone 37.51; eBioscience). In addition, where indicated, cells were transfected with expression plasmids or siRNA 24 h and 72 h, respectively, before co-culture with NKT cells. Mouse IL-2, IL-10, IL-12p70, IL-13 and IL-1b production were assessed by ELISA (OptEIA; BD Biosciences) in supernatants after 24 h of co-culture. Cell stimulation by crosslinking. CD1d crosslinking on freshly isolated colonic IECs was achieved as described previously 32 using plate-bound anti-mCD1d antibody (1B1, BD). In the case of MODE-K cells, surface CD1d was crosslinked by addition of soluble anti-mCD1d antibody (1B1, 10 mg ml 21 , 60 min) followed by washing and addition of secondary goat anti-rat IgG (Biolegend, 10 mg ml
21
) for the indicated time as well as subsequent cell lysis (see later). MODE-K STAT3 phosphorylation in response to iNKT-cell engagement was investigated after coculture with the iNKT-cell hybridoma 24.7 for the indicated time, removal of nonadherent iNKT cells by thorough washing, and cell lysis. Where indicated, MODE-K cells were pre-treated with 19G11 anti-CD1d antibody for blocking of CD1d (10 mg ml 21 , BioXcell). Adenoviruses. Type 5, E1/E3-deleted adenoviruses expressing murine HSP110 (AdHSP110) or Escherichia coli b-galactosidase (AdLacZ) under the control of the cytomegalovirus promoter, were constructed according to the in vitro ligation method 33, 34 . Briefly, murine Hsph1 (NM-013559) was isolated and amplified by PCR from mouse intestinal cDNA using the following primers, cloned into NheI and EcoRI sites of pIRES2-eGFP (Clontech), sequenced, and the resulting plasmid was called pHSP110-IRES2-eGFP. Forward primer: ATAAAGCTAGCGCCACCatgtc ggtggttgggctag, containing an NheI site and a Kozak like sequence; reverse primer: AATTAGAATTCTTAgtccaggtccatgttgacagagc, containing an EcoRI site (the sequence complementary to Hsph1 cDNA is shown in lower case). An NheI-HSP110-KpnI or NheI-HSP110-IRES2-eGFP-NotI fragment from pHSP110-IRES2-eGFP was transferred into pHMCMV6 (pHMCMV6-HSP110 and pHMCMV6-HSP110-IRES2-eGFP, respectively). Subsequently, pAdHM15RGD-CMV6-HSP110 and pAdHM15RGD-CMV6-HSP110-IRES2-eGFP were constructed by ligating I-CeuI/PISceI-digested pAdHM15-RGD and pHMCMV6-HSP110-IRES2-eGFP or pHMCMV6-HSP110. To prepare the virus, a PacI fragment of pAdHM15-RGD-CMV-HSP110 or pAdHM15-RGD-CMV-HSP110 was transfected into 293 cells. The adenoviruses were purified by two rounds of caesium chloride density centrifugation and dialysed against Tris-HCl (pH 7.5). The concentrations of plaque-forming units (p.f.u.) of individual stocks were determined from the tissue culture infectious dose 50 titre. Colon organ culture. Standardized segments (1 cm 3 1 cm) of the transverse colon were washed in cold PBS supplemented with penicillin and streptomycin (GIBCO) and cultured in 24-well flat-bottom culture plates (Falcon) in RPMI 1640 media (GIBCO) for 24 h at 37 uC. Supernatants were analysed for cytokines IL-10, IL-13 and IL-1b by ELISA (all BD). Western blotting. Protein extraction and western blotting were performed as described previously 35 . The following antibodies were used: anti-IL10 (R&D), anti-HSP110 (BD), anti-STAT3 (Cell signaling), anti-pSTAT3 (Cell signaling) and antib-actin (Cell Signaling). Real-time RT-PCR. RNA samples were prepared using an RNeasy Mini Kit and cDNAs were synthesized using the Omniscript RT Kit (Qiagen). Real-time RT-PCR was performed using SYBR Green I Master Mix (Roche) and a CFX96 RealTime System (Bio-Rad). Values were normalized to b-actin. The following primer sets were used: b-actin, 59-GATGCTCCCCGGGCTGTATT-39 and 59-GGGGTA CTTCAGGGTCAGGA-39; Hsph1, 59-CAGGTACAAACTGATGGTCAACA-39 and 59-TGAGGTAAGTTCAGGTGAAGGG-39; Il10, 59-GAGAGCTGCAGGGC CCTTTGC-39 and 59-CTCCCTGGTTTCTCTTCCCAAGACC-39; Tgfb, 59-TGT ACGGCAGTGGCTGAACCA-39 and 59-TGTCACAAGAGCAGTGAGCGCT-39,
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Cd1d1, 59-GCAGCCAGTACGCTCTTTTC-39 and 59-ACAGCTTGTTTCTGGC AGGT-39; Stat3, 59-CCCGTACCTGAAGACCAAGT-39 and 59-ACACTCCGA GGTCAGATCCA-39; Il13, 59-AGCATGGTATGGAGTGTGGACCTG-39 and 59-CAGTTGCTTTGTGTAGCTGAGCAG-39, Ifng 59-TCAGCAACAGCAAGG CGAAAAAGG-39 and 59-CCACCCCGAATCAGCAGCGA-39. Transfection, siRNA treatment and recombinant HSP110. Where indicated, MODE-K cells were transfected with mouse CD40 or CD1d (in pSRa-neo), with SignalSilence Stat3 siRNA II or with SignalSilence Control siRNA (Cell Signaling Technology) using Lipofectamine 2000 (Life Technologies) according to the manufacturer's instructions. Il10 siRNA was obtained from Invitrogen and transduced by Amaxa Nucleofector technology (Lonza) according to the manufacturer's instructions. Cells were used for antigen presentation assays after 72 h or were incubated with the indicated adenoviruses after 48 h at a MOI of 5 before RNA preparation after another 24 h as described earlier. Where indicated, recombinant HSP110 was added at a final concentration of 6 mg ml 21 to MODE-K cells 24 h before RNA extraction. XBP1 splicing assay. The assay was performed as described previously 36 .
In vivo permeability assay. In vivo intestinal permeability was measured using the FITC-labelled dextran (FD-4) method as described previously 37, 38 with modifications. Mice were administered 150 ml of FD-4 (50 mg ml 21 ) by oral gavage before and 18 h after rectal challenge with oxazolone. Serial dilutions of FD-4 were made to generate a standard curve and serum concentrations of FD-4 were determined using a BioTek FLx800 Fluorescence Microplate Reader (BioTek) with an excitation wavelength of 490 nm and emission wavelength of 530 nm. Immunohistochemistry and immunofluorescence. A polyclonal rabbit anti-HSP110 antibody (anti-mouse 1:250, anti-human 1:500; Sigma-Aldrich), an anti-STAT3 (anti-mouse 1:900) and anti-pSTAT3 antibody (anti-mouse 1:350), both from Cell Signaling, as well as a rabbit polyclonal anti-GFP antibody conjugated to FITC (1:1,000) (Novus Biologicals) were used. All images were taken by a digital camera on a Nikon Eclipse Ti microscope. Osmium tetroxide staining of intracellular lipid droplets. Intestinal tissue was fixed in 10% neutral buffered formalin and transferred into 1% osmium tetroxide with periodic shaking. The tissue was rinsed with distilled water and incubated in 0.5% periodic acid, washed and counterstained with haematoxylin and eosin. Microarray analysis. Mttp DIEC and littermate wild-type mice were skin sensitized with oxazolone, and IECs were harvested via colonic epithelial scraping as described previously 35 , either before administration of rectal oxazolone (n 5 2 per group) or 6 h thereafter (n 5 4 per group). Isolated RNAs were pooled for each condition and subjected to transcriptomic analysis with mouse genome 430 2.0 array (Affymetrix) at the Biopolymers Core Facility (Harvard Medical School). Data analysis was performed with Agilent GeneSpring GX and Affymetrix GCOS software under default parameter settings with GC-RMA normalization. Statistical analysis. Statistical testing was performed using the unpaired Student's t-test unless otherwise indicated. The Mann-Whitney U-test was applied when data were demonstrated to not follow a Gaussian distribution, which is indicated in the respective figures legends. Comparisons of mortality were made by analysing Kaplan-Meier survival curves, and the log-rank test was used to assess differences in survival. All P values were two-tailed, and statistical significance was assumed at P , 0.05.
